Risk factors
ProMIS Neurosciences (PMN) risk factors
Item 1A of every ProMIS Neurosciences Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors69 risks9 new9 dropped7 reworded
ProMIS Neurosciences faces risks from third-party reliance for manufacturing and clinical trials of product candidates like PMN310. Nasdaq compliance issues and intellectual property enforcement dominate the risk profile. Integration of artificial intelligence introduces new operational and cybersecurity vulnerabilities.
Filed Mar 25, 2026 - FY2024 10-K risk factors69 risks
ProMIS Neurosciences faces heavy reliance on its lead Alzheimer's disease candidate PMN310, early-stage development risks, and an accumulated deficit of $90.7 million.
Filed Mar 31, 2025